Compound ID | 1342
Class: Macrolide
| Agent Type: | Semisynthetic; Small molecule; Direct acting; Antivirulence; Antibiofilm; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Protein synthesis inhibitor. Also reduces quorum sensing and shows antibiofilm properties |
| Institute where first reported: | Pilva, Zagreb, Croatia |
| Year first mentioned: | 1980 |
| Highest development stage: | Approved by FDA in 1991 |
| Development status: | Approved |
| Reason dropped: | Other formulations were discontinued due to safety and effectiveness reasons |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/447043 |
| Guide to Pharmacology: | azithromycin |
| Citations: |
|